SMAD4 and pancreatic ductal adenocarcinoma: On the other side, many studies including this one published by Li et al. [26] found that downregulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.